Big Bucks
Thursday, April 26th, 2007
For years big drugmakers ignored rare diseases. Now Novartis aims to reap billions of dollars in sales by focusing on them.
Archive for April, 2007
Doctor Voices Dendreon Doubts
Thursday, April 26th, 2007
A second oncologist, Maha Hussain of the University of Michigan, writes a letter to the FDA arguing the prostate drug is not ready for prime time.
Cancer Drugs A Key In MedImmune Purchase
Monday, April 23rd, 2007
Keep an eye on the anti-cancer medicines AstraZeneca is getting with its $15 billion deal.
The Danger In Dendreon
Friday, April 20th, 2007
Why the prostate cancer-fighting biotech is an extremely risky investment.
Brain Windows
Tuesday, April 17th, 2007Brain Windows is a blog devoted to reporting, analyzing and interpreting the latest results in the field of brain imaging technologies, particularly at the levels of systems, circuits, single cells and below. Pretty cool geeky stuff.